Skip to the content
Beyond Type 2
  • About
    • Our Story
    • Founding Partners
    • Board of Directors
    • Leadership Council
    • The Team
    • Join Us
    • Contact
  • Diabetes
    • Type 1 Info
    • Type 2 Info
    • Prediabetes Info
    • Forms of Diabetes
    • Newly Diagnosed
    • Diabetes Management
    • Pregnancy and Diabetes
  • Resources
    • GetInsulin.org
    • Insulin for T2D
    • Diabetes Management
    • Understanding T2D
    • Exercise
    • Food
    • Heart Health
    • Mental Health
    • Continuous Glucose Monitoring (CGM)
    • Veterans with Diabetes
    • Beyond Type 2 Advocacy
  • Stories
    • Diabetes News
    • Type 2 Stories
  • Community
  • En Español
  • About
    • Our Story
    • Founding Partners
    • Board of Directors
    • Leadership Council
    • The Team
    • Join Us
    • Contact
  • Diabetes
    • Type 1 Info
    • Type 2 Info
    • Prediabetes Info
    • Forms of Diabetes
    • Newly Diagnosed
    • Diabetes Management
    • Pregnancy and Diabetes
  • Resources
    • GetInsulin.org
    • Insulin for T2D
    • Diabetes Management
    • Understanding T2D
    • Exercise
    • Food
    • Heart Health
    • Mental Health
    • Continuous Glucose Monitoring (CGM)
    • Veterans with Diabetes
    • Beyond Type 2 Advocacy
  • Stories
    • Diabetes News
    • Type 2 Stories
  • Community
  • En Español

Invisible: ADA_News20

News From DiabetesMine™ D-Data Exchange 2020

The Beyond Type 2 team is spending a day at The DiabetesMine™ D-Data ExChange – this is our report from this enlightening event. 

Diabetes Prevention Program Shows Persistent Reduction of Type 2 Diabetes Development

A 22-year follow up on the Diabetes Prevention Program Outcomes Study (DPPOS) indicates a continued significant reduction in the participants’ risk of developing Type 2 diabetes. Individuals in the...

Disparities in Diabetes and Diabetes Care—What Can We Do About It?

At this ADA 2020 session, systemic racism and implicit bias were clear contributors to poor health and healthcare outcomes for Black and Latinx communities.

Who Has Access to New Oral Diabetes Medications?

Racial and ethnic minorities may have a greater need for newer diabetes medications but functionally have less access. 

FreeStyle Libre 2 Approved for Use in U.S.

The FreeStyle Libre 2 is a 14 day CGM system that transmits data every minute and now includes customizable high and low alerts without the need to scan the device. The Abbott announcement says it wil...

Lifestyle Interventions for Type 2 Diabetes Remission

Type 2 diabetes remission is a hot topic within the T2D community. At the American Diabetes Association's 80th Scientific Sessions, researchers presented data on the impact lifestyle intervention...

Dapagliflozin May Reduce the Onset of Type 2 Diabetes

Research presented at the American Diabetes Association's 80th Scientific Sessions revealed that the SGLT-2 Inhibitor, dapagliflozin, may reduce the onset of Type 2 diabetes when used in patients...

Nationwide Study in France Shows Dramatic Drop in DKA in Type 1 and Type 2 after Starting on FreeStyle Libre

The study included more that 70,000 patients living with diabetes and DKA rates were reduced by 52% for patients with T1D and 47% for patients with T2D.

Closed Loop Updates: Omnipod Horizon and Medtronic 780G data presented at ADA 2020

Data from four new clinical trials involving Hybrid Closed Loop systems, Medtronic 780G and Omnipod 5 Powered by Horizon was presented at ADA 2020.
Instagram has returned invalid data.
  • ABOUT
  • DONATE
  • SHOP
  • PORTFOLIO
  • TERMS OF USE
  • CONTACT
  • 400 CONCAR DR. 03-155
  • SAN MATEO, CA 94402
  •  
  •  
  •  
  •  
  • BEYOND TYPE 1BEYOND TYPE 1 EN ESPAÑOL
  • IN ENGLISHEN ESPANOLBEYOND TYPE 1 AUF DEUTSCHBEYOND TYPE 1 IN ITALIANOBEYOND TYPE 1 EN FRANÇAISBEYOND TYPE 1 IN HET NEDERLANDSBEYOND TYPE 1 PÅ SVENSKABEYOND TYPE 1 EM PORTUGUÊSBEYOND TYPE 1 بالعربية
  • BEYOND TYPE 2BEYOND TYPE 2 EN ESPAÑOLIN ENGLISHEN ESPANOL